MICHELINI, FLAVIA
MICHELINI, FLAVIA
Universita' degli Studi di MILANO
Mostra
records
Risultati 1 - 3 di 3 (tempo di esecuzione: 0.0 secondi).
Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study
2024 B.T. Li, F. Meric-Bernstam, A. Bardia, Y. Naito, S. Siena, P. Aftimos, I. Anderson, G. Curigliano, M. de Miguel, M. Kalra, D. Oh, J.O. Park, S. Postel-Vinay, S.Y. Rha, T. Satoh, I. Spanggaard, F. Michelini, A. Smith, K.K. Machado, C. Saura
Bystander effect of antibody-drug conjugates: fact or fiction?
2022 F. Giugliano, C. Corti, P. Tarantino, F. Michelini, G. Curigliano
A NEW CLASS OF NON-CODING RNA CONTROLS THE DNA DAMAGE RESPONSE AND DNA REPAIR
2014 F. Michelini
| Titolo | Data di pubblicazione | Autori | Tipo | File | Abstract |
|---|---|---|---|---|---|
| Trastuzumab deruxtecan in patients with solid tumours harbouring specific activating HER2 mutations (DESTINY-PanTumor01): an international, phase 2 study | 2024 | Siena, SalvatoreCurigliano, GiuseppeMichelini, Flavia + | Article (author) | - | |
| Bystander effect of antibody-drug conjugates: fact or fiction? | 2022 | Giugliano, FedericaCorti, ChiaraTarantino, PaoloMichelini, FlaviaCurigliano, Giuseppe | Article (author) | - | |
| A NEW CLASS OF NON-CODING RNA CONTROLS THE DNA DAMAGE RESPONSE AND DNA REPAIR | 2014 | MICHELINI, FLAVIA | Doctoral Thesis | - |